Superstring Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Superstring Capital Management LP
CRD #305743
SEC #801-118766
CIK #0001931118
AUM 339.5 M (2026-03-30)
Employees 5 (60% Investors, 0% Brokers)
Fees
Minimum
Phone212-257-5690
Address150 E 52nd St
New York, NY 10022
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
4503602701809002010201520212027
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
Item 5 - Fees and Compensation

Management Fees

With respect to the Funds and SMA, Superstring predominantly receives Management Fees at
an annual rate between 1.0%-2.0% (the “Management Fee”), depending on the particular share
class of the Funds. The Management Fee is deducted from the Funds quarterly in advance and
prorated for any investment period less than a full calendar quarter. The Management Fee is
refundable if the advisory contract is cancelled prior to the end of a payment period. The
Management Fees is described in more detail in the relevant Fund Documents.

Superstring Capital Management, LP                                           Form ADV Part 2A

While the Management Fee is generally non-negotiable, Superstring may waive or modify the
Management Fee for certain Investors that are members, employees or affiliates of Superstring,
relatives of such persons, or for certain large or strategic Investors.

Other Expenses

The Funds bear their own expenses and generally are allocated a proportionate share of
investment and operational expenses. These expenses may include, among other things: legal,
administration, audit and accounting expenses (including third-party accounting services);
proxy voting services; investment expenses such as commissions, research fees, market data
and similar expenses; interest on margin accounts and other indebtedness; borrowing charges
on securities sold short; custodial fees; bank service fees; Fund-related insurance costs
(including D&O and E&O insurance for Superstring and the general partner); and any other
expenses related to the purchase, sale, or transmittal of the Funds’ assets. The inclusion of an
expense category in a Fund’s Fund Documents will not impose on Superstring an obligation to
charge an expense (or the full amount of that expense) to that Fund; instead, permitted
expenses will be allocated and charged in Superstring’s discretion to the Fund(s) it deems
appropriate

If Superstring incurs any of the above expenses on behalf of the Funds, then the Firm will
allocate such expenses among the Funds in proportion to the size of the investment made in
the activity by each Fund, to the entity to which the expense relates, or in such other manner
as Superstring considers fair and reasonable.

The Firm shall bear its own overhead costs or expenses, including, without limitation, the
salaries and benefits of the Firm’s employees performing the services as described in the Fund
Documents.

For a more detailed discussion of brokerage and transaction costs, Investors are directed to
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
Item 7 - Types of Clients

The Firm provides discretionary advice to its Funds and SMA. The Fund Documents provide
the eligibility criteria and minimum investment requirements.

In general, each Investor in the Funds is a “qualified purchaser” as defined in Section 2(a)(51)
of the Investment Company Act of 1940, as amended. Although Superstring has the authority
to accept subscriptions of a lesser amount, the required minimum initial investment is generally
US$5,000,000 for the Hedge Fund and US$1,000,000 for the PE Fund.

Superstring also manages one separately managed account.
Sector Form 13F Holdings Value ($M)
Summit Therapeutics PLC 16.9
Health Sciences Acquisitions Corp 8.9
UNUM Therapeutics Inc 8.7
Adventrx Pharmaceuticals Inc 8.7
UroGen Pharma Ltd 7.0
MIND Medicine Mindmed Inc 6.6
VIR Biotechnology Inc 6.5
Vaxcyte Inc 6.4
Celldex Therapeutics Inc 5.7
Sionna Therapeutics Inc 5.7
View All
Holdings by Sector ($M)
190152114763802024202520262027
Type Form D Funds Date Sold AUM
PE Superstring Private Opportunites Fund I LP [2022-03-30] 9.8 M 34.4 M
Offered $100,000,000 · Filed 2021-06-14 (D) · Exemption 506(b), 3(c)(7) · Remaining $90,180,000 · Duration One year or less · Revenue Decline to Disclose
HF Superstring Capital Master Fund LP [2019-10-18] 69.8 M 281.3 M
Filed 2020-11-23 (D/A) · Exemption 506(b), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 315.7
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 1 23.8
Total 6 339.5
By Discretionary
Discretionary 6 339.5
Non-Discretionary 0 0.0
Total 6 339.5
By Non-United States Persons
Non-United States Persons 181.0
United States Persons 158.5
Total 6 339.5
Form D Directors Role # Filings # Firms 2011 - 2026
George Song Executive Officer 6 2
Superstring Capital Management LP Promoter 4 2
Superstring Capital Fund GP LLC Executive Officer 3 2
Ting Guo Executive Officer 3 2
EDGAR Form CIK 2011 - 2026
13F-HR [0001931118]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI5493000JPLGPU6IXS139
Comparable Firms State AUM
Flight Deck Capital LP
CA 358.7 M
Forager Capital Management LLC
AL 352.9 M
Triatomic Management LP
CA 346.3 M
Vedanta Management LP
NY 345.6 M
Borderless Management LLC
FL 345.4 M
North Run Capital LP
MA 334.5 M
Opus Investment Management LLC
NY 331.9 M
Wolf River Capital Management LLC
TN 328.7 M
Gordonmd Global Investments LP
CA 322.3 M
Talara Capital Management LLC
NJ 317.6 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com